AKA
a.k.a. Brands Holding Corp.
AKA has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over AKA overall, supported by stronger fundamentals and stronger modeled upside.
AKA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
AKA's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AKA PE Valuation
AKA has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
AKA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect AKA's losses to shrink, with revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AKA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.72 | -$0.26 |
| Q2 2026 | -$2.48 | +$0.03 |
| Q1 2026 | -$2.81 | -$0.42 |
| Q4 2025 | -$2.93 | -$0.47 |
| Q3 2025 | -$2.46 | +$0.46 |
| Q2 2025 | -$2.51 | +$6.48 |
| Q1 2025 | -$2.39 | +$6.86 |
| Q4 2024 | -$2.46 | +$6.78 |
AKA is still losing money, but far less than before: $2.72 per share over the past year, against $24.10 at its worst in late 2023.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
AKA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161.3M | +9.7% |
| Q2 2026 | $160.1M | -0.3% |
| Q1 2026 | $132.5M | +3% |
| Q4 2025 | $164M | +3.1% |
| Q3 2025 | $147.1M | -1.9% |
| Q2 2025 | $160.5M | +7.8% |
| Q1 2025 | $128.7M | +10% |
| Q4 2024 | $159M | +6.8% |
AKA's revenue grew through 2024 and has held roughly level since: $161M last quarter, up 9.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.6% | -1.6 points |
| Q2 2026 | 0.7% | +1 points |
| Q1 2026 | -3.1% | +1.1 points |
| Q4 2025 | -6.6% | -4.8 points |
| Q3 2025 | -1% | +0.4 points |
| Q2 2025 | -0.3% | -0.7 points |
| Q1 2025 | -4.2% | +1 points |
| Q4 2024 | -1.8% | +1.9 points |
AKA has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over AKA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
AKA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.4M | -2444% |
| Q2 2026 | $18.2M | +146% |
| Q1 2026 | -$6.4M | -$1.1M |
| Q4 2025 | -$3M | -198% |
| Q3 2025 | $317K | +$7.4M |
| Q2 2025 | $7.4M | +388% |
| Q1 2025 | -$5.3M | +$3.1M |
| Q4 2024 | $3.1M | -79% |
AKA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
AKA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +105K shares |
| 1 year | +2.5% | +267K shares |
| 3 years | +3% | +316K shares |
| 5 years | +3% | +326K shares |
| Available history | +16% | +1.5M shares |
AKA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1,000 |
| Q3 2025 | $1.6M |
| Q2 2025 | $110,000 |
| Q1 2025 | $257,000 |
| Q4 2024 | $243,000 |
AKA has spent almost nothing on buybacks in the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
AKA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 69.0x | High |
| Q2 2026 | 22.5x | High |
| Q1 2026 | 72.1x | High |
| Q3 2025 | 11.3x | High |
| Q2 2025 | 20.2x | High |
| Q1 2025 | 36.8x | High |
| Q3 2022 | 5.5x | High |
| Q2 2021 | 3.8x | Elevated |
AKA's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AKA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 15.3 | Oversold |
AKA's weekly RSI is 34 (neutral) and its Stochastic is 15 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
AKA PE vs Consumer Cyclical Sector
AKA has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
AKA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 15% below |
| 20 week MA | $10.7 | 18% below |
| 50 week MA | $10.6 | 16% below |
| 100 week MA | $11.7 | 25% below |
| 200 week MA | $12.1 | 27% below |
AKA is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
AKA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $120.0 | $104.8 | -13% |
| 2022 | $104.8 | $16.0 | -85% |
| 2023 | $16.0 | $8.05 | -50% |
| 2024 | $8.05 | $19.4 | +141% |
| 2025 | $19.4 | $11.4 | -41% |
| 2026 YTD | $11.4 | $8.82 | -22% |
AKA has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.